Joel Scanlon

Joel Scanlon

Digital Specialist and Founder of News-Medical.Net

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Articles from Joel

Concordia Resource Begins Core Drilling at Albisu Property

Victory Nickel Receives Additional Positive Results from Minago Project

Campbell Newman Happy to Offload CSG Shares

Newcrest's Gold Production Back on Track

Confusion Reigns Over Zimbabwe Indigenization Proposals

CoAL of Africa Gets 'Go-Ahead' for Vele Colliery

Tree Sitters Return to Protest Coal River Mountain

Ur-Energy Begins Drilling Program at Lost Creek Project

Glass Earth Gold Reports Surface Channel Sampling Results from Muirs Prospect

Concordia Resources Reports Confirmation Sampling Results from Providencia Property

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.